Deferoxamine promotes osteoblastic differentiation in human periodontal ligament cells via the nuclear factor erythroid 2‐related factor‐mediated antioxidant signaling pathway
Authors:
- 1 October 2013
- journal article
- research article
- Published by Wiley in Journal of Periodontal Research
- Vol. 49 (5) , 563-573
Abstract
Background and Objective: Recently it was reported that deferoxamine (DFO), an iron chelator, stimulates bone formation from MG63 and mesenchymal stem cells, but inhibits differentiation in rat calvarial cells; however, the effect of DFO on osteoblastic differentiation in human periodontal ligament cells (hPDLCs) has not been reported. The aim of this study was to investigate the effects and the possible underlying mechanism of DFO on osteoblastic differentiation of hPDLCs.Material and Methods: The effect of DFO on osteoblast differentiation was determined by the staining intensity of calcium deposits with Alizarin red and by RT‐PCR analysis of the expression of osteoblastic markers. Signal transduction pathways were analyzed by western blotting.Results: DFO increased osteogenic differentiation in a concentration‐dependent manner by expression of the mRNA for differentiation markers and calcium nodule formation. Exposure of hPDLCs to DFO resulted in increases in the production of reactive oxygen species and in the levels of nuclear factor erythroid 2‐related factor (Nrf2) protein in nuclear extractions, as well as a dose‐dependent increase in the expression of Nrf2 target genes, including glutathione (GSH), glutathione S‐transferase, γ‐glutamylcysteine lygase, glutathione reductase and glutathione peroxidase. Pretreatment with Nrf2 small interfering RNA, GSH depletion by buthionine sulfoximine and diethyl maleate, and with antioxidants by N‐acetylcysteine and vitamin E, blocked DFO‐stimulated osteoblastic differentiation. Furthermore, pretreatment with GSH depletion and antioxidants blocked DFO‐induced p38 MAPK, ERK, JNK and nuclear factor‐kappaB pathways.Conclusion: These data indicate, for the first time, that nontoxic DFO promotes osteoblastic differentiation of hPDLCs via modulation of the Nrf2‐mediated antioxidant pathway.Keywords
Funding Information
- National Research Foundation of Korea
- Korea government (2012R1A5A2051384)
This publication has 64 references indexed in Scilit:
- Deferoxamine reverses radiation induced hypovascularity during bone regeneration and repair in the murine mandibleBone, 2012
- Mitochondrial Complex III ROS Regulate Adipocyte DifferentiationCell Metabolism, 2011
- Cellular Antioxidant Levels Influence Muscle Stem Cell TherapyMolecular Therapy, 2010
- Nrf2:INrf2 (Keap1) signaling in oxidative stressFree Radical Biology and Medicine, 2009
- Promotion of osteogenesis through β-catenin signaling by desferrioxamineBiochemical and Biophysical Research Communications, 2008
- Differential regulation of iron chelator-induced IL-8 synthesis via MAP kinase and NF-κB in immortalized and malignant oral keratinocytesBMC Cancer, 2007
- Chalcone inhibits the activation of NF-κB and STAT3 in endothelial cells via endogenous electrophileLife Sciences, 2007
- Effect of F-spondin on cementoblastic differentiation of human periodontal ligament cellsBiochemical and Biophysical Research Communications, 2006
- Role of Ascorbic Acid in Periodontal Ligament Cell DifferentiationJournal of Periodontology, 2004
- Ascorbic Acid Induces Collagenase-1 in Human Periodontal Ligament Cells but Not in MC3T3-E1 Osteoblast-Like Cells: Potential Association Between Collagenase Expression and Changes in Alkaline Phosphatase PhenotypeJournal of Bone and Mineral Research, 2003